UC San Diego Health
Gyencologic Oncology
Ramez Eskander, MD, is a board-certified gynecologic oncologist who specializes in the comprehensive management of female reproductive system cancers, including ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes diagnostic and therapeutic procedures, state-of-the-science treatment strategies, as well as minimally invasive (robotic) surgery, hyperthermic intraperitoneal chemotherapy (HIPEC) and novel drugs. Dr. Eskander is experienced in developing and leading national and international clinical trials, with an aim to provide individuals with access to innovative medicines during their treatment. As an associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences, Dr. Eskander instructs medical students, residents, and fellows at UC San Diego School of Medicine. He is also the gynecologic oncology fellowship director. Dr. Eskander’s research focuses on immunotherapy, targeted therapies, new combinatorial treatment approaches and a better understanding of the implications of molecular tumor testing on treatment outcomes and identification of new treatment options.
Moderator of 3 Sessions
Session Type
Poster Rounds & Sponsor Conversation Break
Date
09/29/2022
Session Time
11:25 AM - 11:55 AM
Room
Sponsor Conversation Area
Chair(s)
Session Icon
Session Description
Poster Rounds Groups E1, E2 & E3. For the full schedule, please click on the Poster Rounds green button on top of the interactive program or visit the IGCS 2022 Mobile App.
Session Type
Master Session
Date
09/29/2022
Session Time
01:55 PM - 04:10 PM
Room
Hall 501
Chair(s)
Session Icon
Session Description
In this session we will describe the exciting transformation of the endometrial cancer landscape in the last several years, moving to molecular classification for aid in pathological categorization and providing prognostic and predictive information with which to guide management and clinical trials. Strategies for implementation of molecular classification in both low and high resource settings will be shared, as well as when additional molecular or pathological parameters might add value. Current challenges or as yet unanswered questions in endometrial cancer management will be addressed.
Session Type
Plenary Session
Date
09/29/2022
Session Time
04:55 PM - 05:55 PM
Room
Hall 501
Session Icon
Session Description
This session consists of four oral abstract presentations followed by distillations by renowned speakers.
Presenter of 5 Presentations
Distillation
Session Type
Plenary Session
Date
10/01/2022
Session Time
03:55 PM - 05:25 PM
Room
Hall 501
Session Icon
Lecture Time
05:07 PM - 05:12 PM
Introductions
Session Name
Session Type
Industry Symposia
Date
09/30/2022
Session Time
12:25 PM - 01:55 PM
Room
Hall 405
Presenter
Lecture Time
12:25 PM - 12:35 PM
Conclusions and Remarks
Session Name
Session Type
Master Session
Date
09/29/2022
Session Time
01:55 PM - 04:10 PM
Room
Hall 501
Session Icon
Presenter
Lecture Time
04:05 PM - 04:10 PM
PARP Inhibitors in Frontline Maintenance: The Evolving Treatment Paradigm
Session Type
Industry Symposia
Date
10/01/2022
Session Time
12:35 PM - 02:05 PM
Room
Hall 405
Lecture Time
12:45 PM - 01:05 PM
Opening / Introduction
Session Name
Session Type
Master Session
Date
09/29/2022
Session Time
01:55 PM - 04:10 PM
Room
Hall 501
Session Icon
Presenter
Lecture Time
01:55 PM - 02:00 PM